MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Archives
Archives... Don't Miss Anything, Ever!
Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Dabur: Sluggish topline, improved OPM
Oct 30, 2002Dabur India, the ayurvedic products major, has reported a marginal 2% topline growth during the September quarter 2002. The company had reported a 7% topline growth during the June quarter. Cost efficiencies led to a 160 basis point expansion in operating margins, thus helping the company report nearly 24% growth in 2QFY03 net profit.
Dabur: Encouraging numbers…
Jul 31, 2002Dabur India, the ayurvedic products major, has reported an encouraging 7% topline growth in June quarter. It ability to control costs led to a 100 basis point expansion in operating margins, thus helping the company report an over 30% growth in 1QFY03.
Dabur: In a trough
Jun 12, 2002Slowdown and competition seems to have finally caught with Dabur Limited, India's largest ayurvedic FMCG company. In 4QFY02, the company actually reported an 8% decline in topline (the first negative in last few years). Its net profit saw a 67% decline during the said quarter.
Dabur: The pressure continues
Feb 5, 2002Dabur India Limited, the ayurvedic products major, reported a marginal 1% increase in topline and a mere 2% growth in net profits during the December quarter of FY02.
Dabur: Sluggish numbers
Nov 28, 2001Dabur India declared its first half FY02 results yesterday. The company reported a small 3% growth in turnover and a 13% growth in bottomline during this period. Comparing 2QFY02 with the corresponding quarter last year, Dabur managed a 5% growth in turnover and a 10% growth in net profits.
Dabur: Topline concerns
Jul 26, 2001Dabur India has posted a 23% growth in 1QFY02 net profit to Rs 88 m. This growth in bottomline has come despite a negligible topline growth. Reduction of interest cost by 8% and an 11% jump in other income contributed to the company's bottomline growth.
Dabur 3QFY01 net jumps 42%
Jan 30, 2001Dabur India, the ayurvedic products giant has declared a 42% jump in its 3QFY01 bottomline. This surge was on the back of a 10% jump in its topline during the period.
Dabur: In the reckoning
Aug 31, 2000Dabur India, the 115 year old FMCG ‘ayurvedic’ company operates in the niche natural/ayurvedic products segment with a product folio of over 500 products. But despite its range, investors have been wary of investing in this company simply because of its unrelated diversifications and a family run business.
Dabur and Zandu: Distant cousins
May 19, 2000To a layman Dabur and Zandu are companies operating in the niche ayurveda segment. At first glance these companies seem alike because of their 'ayurvedic' image. But probe a little further and you find two very different entities.
Disappointing results from Zandu
Feb 2, 2000Zandu's turnover has declined 16.6% while the net profits have declined by 21%. The company has been sucessful in mainting its operating margins.
Dabur in talks for Zandu for possible merger
Dec 24, 1999A possible merger between the two ‘Chyavanprash’ giants Dabur and Zandu is brewing. Dabur has reportedly offered the Zandu management a price of Rs. 6800-7000 per share. Both the management’s have however denied the talks.
Zandu posts 26% decline in net
Oct 27, 1999Zandu Pharmaceuticals has posted a 26% decline in net during the quarter ended 30th September 1999. The company has been adversely affected by the sharp jump in interest and depreciation expenditure.
|
| |
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.